Smith & Nephew plc (SNN)

NYSE: SNN · IEX Real-Time Price · USD
25.36
-0.98 (-3.72%)
At close: Mar 28, 2024, 4:00 PM
25.50
+0.14 (0.55%)
After-hours: Mar 28, 2024, 7:55 PM EDT

Company Description

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally.

It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.

The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints.

In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions.

Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems.

The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Smith & Nephew plc
Smith & Nephew logo
Country United Kingdom
Founded 1856
IPO Date Nov 16, 1999
Industry Medical Devices
Sector Healthcare
Employees 19,081
CEO Dr. Deepak S. Nath Ph.D.

Contact Details

Address:
Building 5, Croxley Park, Hatters Lane
Watford, Hertfordshire, X0 WD18 8YE
United Kingdom
Phone 44 (0) 1923 477 100
Website smith-nephew.com

Stock Details

Ticker Symbol SNN
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000845982
CUSIP Number 83175M205
ISIN Number US83175M2052
SIC Code 3842

Key Executives

Name Position
Dr. Deepak S. Nath Ph.D. Chief Executive Officer and Director
Anne-Francoise Nesmes Chief Financial Officer and Executive Director
Paul Connolly President of Global Operations
Andrew Swift Vice President of Investor Relations
Helen Barraclough Group General Counsel and Company Secretary
Alison Parkes Chief Compliance Officer and Compliance APAC
Joe Metzger Senior Vice President of Marketing Services and Communications
Philip G. Cowdy Chief Corporate Development and Corporate Affairs Officer
Elga Lohler Chief Human Resources Officer
Dr. Vasant Padmanabhan Ph.D. President of Research and Development and Ear, Nose & Throat

Latest SEC Filings

Date Type Title
Mar 28, 2024 6-K Report of foreign issuer
Mar 22, 2024 CERT Certification by an exchange approving securities for listing
Mar 20, 2024 8-A12B Registration of securities
Mar 20, 2024 6-K Report of foreign issuer
Mar 15, 2024 424B5 Filing
Mar 14, 2024 6-K Report of foreign issuer
Mar 14, 2024 6-K Report of foreign issuer
Mar 14, 2024 6-K Report of foreign issuer
Mar 14, 2024 FWP Free Writing Prospectus
Mar 13, 2024 6-K Report of foreign issuer